Ilhomjon Butabekov

5 ta ish

Tashkent Pediatric Medical Institute

1. Why do tuberculosis patients default in Tashkent City, Uzbekistan? A qualitative study.

   Epco Hasker, Maksad Khodjikhanov, S Sayfiddinova +7

   Maqola20104 iqtibos

   ABIABI:AkademIndex/2026.other.163909

2. Treatment of multidrug-resistant tuberculosis in Uzbekistan from 2012 to 2018: does practice follow policy?

   Ruzilya Usmanova, Nargiza Parpieva, Irina Liverko +8

   MaqolaTuberculosis Research and Epidemiology20210 iqtibos

   ABIABI:AkademIndex/2021.article.010203

3. The impact of the COVID-19 pandemic on tuberculosis detection in Tashkent, Uzbekistan

   Ruzilya Usmanova, Nargiza Parpieva, Irina Liverko +6

   MaqolaDiverse Scientific Research Studies20230 iqtibos

   ABIABI:AkademIndex/2023.article.011428

4. How much should we still worry about QTc prolongation in rifampicin-resistant tuberculosis? ECG findings from TB-PRACTECAL clinical trial

   Ilaria Motta, Martina Cusinato, Andrew Ludman +15

   MaqolaOAOchiq kirishCardiac electrophysiology and arrhythmiasAntimicrobial Agents and Chemotherapy20240 iqtibos

   ABIABI:AkademIndex/2024.article.000869

5. The effectiveness of pulmonary tuberculosis treatment during the COVID-19 pandemic

   Ruzilya Usmanova, Nargiza Parpieva, Irina Liverko +6

   MaqolaCOVID-19 Prevention and Impact20240 iqtibos

   ABIABI:AkademIndex/2024.article.008693